In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

S Laukkanen; T Grönroos; P Pölönen; H Kuusanmäki; J Mehtonen; J Cloos; G Ossenkoppele; B Gjertsen; B Øystein; C Heckman; M Heinäniemi; M Kontro; O Lohi

doi:https://doi.org/10.1038/bcj.2017.87

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

S Laukkanen, T Grönroos, P Pölönen, H Kuusanmäki, J Mehtonen, J Cloos, G Ossenkoppele, B Gjertsen, B Øystein, C Heckman, M Heinäniemi, M Kontro, O Lohi

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	e604
Journal	Blood Cancer Journal
Volume	7
Issue number	9
DOIs	https://doi.org/10.1038/bcj.2017.87
Publication status	Published - 8 Sept 2017

Keywords

Journal Article

Access to Document

https://doi.org/10.1038/bcj.2017.87

Cite this

@article{953293651ad84dcd8170d29a7458a237,

title = "In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL",

keywords = "Journal Article",

author = "S Laukkanen and T Gr{\"o}nroos and P P{\"o}l{\"o}nen and H Kuusanm{\"a}ki and J Mehtonen and J Cloos and G Ossenkoppele and B Gjertsen and B {\O}ystein and C Heckman and M Hein{\"a}niemi and M Kontro and O Lohi",

year = "2017",

month = sep,

day = "8",

doi = "https://doi.org/10.1038/bcj.2017.87",

language = "English",

volume = "7",

pages = "e604",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

AU - Laukkanen, S

AU - Grönroos, T

AU - Pölönen, P

AU - Kuusanmäki, H

AU - Mehtonen, J

AU - Cloos, J

AU - Ossenkoppele, G

AU - Gjertsen, B

AU - Øystein, B

AU - Heckman, C

AU - Heinäniemi, M

AU - Kontro, M

AU - Lohi, O

PY - 2017/9/8

Y1 - 2017/9/8

KW - Journal Article

U2 - https://doi.org/10.1038/bcj.2017.87

DO - https://doi.org/10.1038/bcj.2017.87

M3 - Article

C2 - 28885610

SN - 2044-5385

VL - 7

SP - e604

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 9

ER -